Table 2.
Isolate | Species | Ampicillin (10 µg) | Colistin sulfate (10 µg g) | Doxycycline (30 µg) | Enrofloxacin (15 µg) | Erythromycin (15 µg) | Fosfomycin (200 µg) | Ceftiofur (30 µg) | Neomycin (10 µg) | Kanamycin (30 µg) | Sulfonamides (300 µg) | Trimethoprim (25 µg) | Tetracycline (30 µg) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B700/18-1 | Dietzia sp. | S | R | — | S | S | R | S | — | I | S | R | S |
B700/18-2 | Acinetobacter sp. | S | S | S | S | — | — | I | S | S | S | S | S |
B700/18-3 | Arthrobacter gandavensis | — | R | — | S | — | — | S | S | S | S | S | S |
B700/18-5 | Streptococcus sp. | S | R | — | I | S | — | S | — | R | S | S | I |
B700/18-8 | Pantoea sp. | R | S | S | S | — | — | S | S | S | S | S | S |
B700/18-9 | Pseudomonas putida | — | S | — | I | — | — | R | S | S | S | I | S |
B700/18-10 | Citrobacter sp. | R | S | S | S | — | — | S | S | S | S | S | S |
B700/18-15 | Rothia dentocariosa | — | R | — | S | S | — | S | — | I | S | S | S |
B700/18-16 | Corynebacterium sp. | — | R | — | S | S | — | S | — | S | S | S | S |
B700/18-18 | Streptomyces sp. | — | S | — | S | — | — | R | — | R | S | S | I |
B700/18-19 | Staphylococcus haemolyticus | S | R | — | S | S | — | S | — | S | S | S | S |
I = intermediate; R = resistant (in bold); S = sensitive; — = susceptibility testing is not recommended; the species is a poor target for therapy with the agent.